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Summary: Viral infection results in the generation of non-self
RNA species in the cells, which is recognized by retinoic acid
inducible gene-I-like receptors (RLRs), and initiates innate an-
tiviral responses, including the production of proinflammato-
ry cytokines and type I interferon. In this review, we
summarize reports on virus-specificity of RLRs, structures of
non-self RNA patterns, structural biology of RLRs, and the sig-
naling adapter molecules involved in antiviral innate immu-
nity.
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RIG-I-like receptors (RLRs)
Pattern recognition receptors (PRRs) are essential in innate
immunity. Major PRRs are Toll-like receptors (TLRs), retinoic
acid inducible gene-I (RIG-I)-like receptors (RLRs), and
nucleotide oligomerization domain (Nod)-like receptors
(NLRs) (1–3 2). TLR3, TLR7, TLR8, and TLR9 detect viral
nucleic acids in endosome (4–8). These receptors essentially
sense extracellular molecules incorporated into endosome by
endocytosis. These sensors detect viral nucleic acids, released
from virus-infected cells, and activate subsequent immune
reactions. RLRs detect replicating viruses in cytoplasm, partic-
ularly at early phase of viral infection. Some of the NLRs sense
viral infection to initiate inflammatory responses. Activation
of innate immune responses lead to the induction of type I
and III interferon (IFN) and inflammatory cytokines, whose
antiviral activity blocks viral replication and facilitate the acti-
vation of antigen-presenting cells to activate antigen-specific
immunity to eradicate the viral pathogens.
RLRs include RIG-I, MDA5, and LGP2, all of which contain
a DExD ⁄H box helicase domain (9, 10). The helicase domain
retains catalytic activity to unwind double stranded RNA

















































dependent manner (11); however, unwinding per se may not
be inducing antiviral activity. RIG-I and MDA5 contain tan-
dem caspase recruitment and activation domain (CARD) at
their amino-termini. Forced over expression of the CARD
alone is sufficient to drive antiviral signaling resulting in IFN
production, showing that this domain is responsible for sig-
naling. Indeed, the CARD of RIG-I interacts with another
CARD-containing molecule, interferon-b promoter stimulator
1(IPS-1) (also termed as MAVS, VISA, and Cardif) (12–15).
Over expression of full-length RIG-I exhibits low basal activ-
ity. Furthermore, although IFN treatment strongly induces
RIG-I protein, IFN treatment alone does not activate IFN
genes. Thus, an autorepression model has been proposed. It
was demonstrated that a region of RIG-I acts as repression
domain, which functions in cis as well as trans. LGP2 also
retains repression domain; however, the corresponding
region of MDA5 does not exhibit repression function. The
C-terminus of RLRs consists of a domain [C-terminal domain
(CTD)] and is responsible for binding with dsRNA. It has been
hypothesized that binding of viral RNA with RIG-I induces
conformational change in the presence of ATP to unmask
CARD, but no report has experimentally demonstrated the
conformational change so far.
Recognition of RNA viruses by RLRs
Based on the gene-targeting studies, it has been revealed that
RLRs are essential for the production of type I IFNs and proin-
flammatory cytokines, such as interleukin-6 (IL-6), in
response to viral infection. Double knockout cells for RIG-I
and MDA5 produce no significant IFN upon viral infection,
showing that these receptors are essential for sensing cytoplas-
mic viral RNA (16).
Cells lacking RIG-I are defective in producing type I IFNs
and inflammatory cytokines in response to various RNA
viruses including Newcastle disease virus (NDV) (Paramyxo-
viridae), Sendai virus (SeV) (Paramyxoviridae), vesicular
stomatitis virus (VSV) (Rhabdoviridae), influenza A virus
(Orthomyxoviridae), or Japanese encephalitis virus (JEV)
(Flaviviridae), while MDA5-deficient cells respond normally
to these viruses (16, 17). In contrast, the production of IFN in
response to several picornaviruses, including encephalomyo-
carditis virus (EMCV), Mengo virus, and Theiler’s virus, is
abrogated in MDA5-deficient cells but not in cells lacking
RIG-I (17, 18). Murine norovirus-1 (Caliciviridae) and mur-
ine hepatitis virus (Coronaviridae) are recognized by MDA5
(19, 20). In addition to JEV, another flavivirus, hepatitis C
virus (HCV) is also recognized by RIG-I, while both RIG-I and
MDA5 likely recognize Dengue virus and West Nile virus
(Flavivirus), redundantly (21–23). A vaccine strain of measles
virus (Paramyxoviridae) activates IFN through the activation
of both RIG-I and MDA5, whereas the wildtype measles virus
fails to induce type I IFN production (24). Reovirus, whose
genome consists of segmented dsRNA, induces IFN produc-
tion mainly through MDA5 with minor contribution from
RIG-I (25).
Over expression of LGP2, which lacks CARD, resulted in
diminished IFN production by virus (10). However, LGP2
knockout cells exhibited attenuated IFN production upon
infection of VSV or EMCV (26), suggesting that LGP2 cooper-
ates with either RIG-I or MDA5 to sense viral RNA under
physiological conditions. Influenza A virus-induced IFN pro-
duction was normal in LGP2-deficient cells, suggesting that
LGP2 specifically senses particular RNA patterns.
A DNA virus, Epstein–Barr virus (EBV), is reported to pro-
duce small RNAs that induce RIG-I-mediated IFN responses
(27). Another DNA virus, Herpes simplex virus (HSV), is also
reported to activate both RIG-I- and MDA5-dependent IFN
responses via dsRNA produced during its replication (28).
RNA ligands of RLRs
Polyriboinosinic:polyribocytidylic acid
Polyriboinosinic:polyribocytidylic acid (polyI:C), a synthetic
dsRNA, which was selected as a potent non-viral IFN inducer,
acts as a ligand for TLR3 and RLRs (4, 25). Although the
mechanism underlying is not known, poly I:C exhibits highest
activity among the possible combinations of RNA homopoly-
mer duplexes. Poly I:C is generated by annealing poly I and
poly C, which are synthesized by polynucleotide phosphory-
lase. This enzyme catalyzes the polymerization of nucleotide
diphosphate, thus poly I:C harbors a 5¢-diphosphate (29).
Two groups demonstrated that MDA5 is essential for poly
I:C-mediated IFN production by gene targeting (16, 18). The
specificity originates from the length of dsRNA rather than
base composition (25). Commercial poly I:C runs as dsRNA
of 4–8 kbp in gel electrophoresis. Partial digestion of the poly
I:C with a dsRNA specific endonuclease, RNaseIII, led to the
generation of trimmed poly I:C of about 300 bp. This short
poly I:C activates RIG-I. Interestingly, short poly I:C fails to
activate MDA5, and long poly I:C is incapable of activating
RIG-I, although both of these bind to long and short poly I:C.
Therefore, both RIG-I and MDA5 are necessary to sense vari-
ous length of dsRNA. The precise mechanism of size discrimi-
nation by RIG-I and MDA5 is not known.
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RNA transcribed from DNA template by T7 RNA polymerase
is a strong inducer of type I IFN (30). Further studies revealed
that 5¢-triphosphate containing RNA, such as genomes of
most RNA viruses, and in vitro transcripts are selectively recog-
nized by RIG-I (31, 32). Since the 5¢-triphosphate moieties of
most host transcripts are removed by adding 7-methyl-guano-
sine cap (in the case of mRNA) or by processing (tRNA and
rRNA), these self-RNAs are refractory to detection by RIG-I.
However more recently, it was revealed that 5¢-triphosphate
per se is not sufficient for RIG-I activation. This is consistent
with observations that dsRNA without 5¢-triphosphate can be
recognized by RIG-I particularly for long dsRNA. Therefore,
dsRNA structure is prerequisite for RIG-I activation and
5¢-triphosphate facilitates the recognition of short dsRNA. In
addition, removal of 5¢-triphosphate is a viral strategy to
avoid recognition by RIG-I. A viral peptide, VPg, is cova-
lently attached to the 5¢ end of Picornaviridae RNA, thus
lacking 5¢-triphosphate (33). Hantaan virus (HTNV), Cri-
mean-Congo hemorrhagic fever virus (CCHFV) (Bunyaviri-
dae), and Borna disease virus (BDV) (Bornaviridae) do not
trigger RIG-I-mediated IFN responses, because the 5¢-triphos-
phate structure of these viral genomic RNA is removed by
processing (34).
Transfection of AT-rich dsDNA (typically a synthetic poly-
dAdT:polydAdT) results in the type I IFN induction(35). It
was revealed that polydAdT:polydAdT is transcribed by host
DNA-dependent RNA polymerase III and that the resultant
5¢-triphosphate dsRNA is detected by RIG-I (36, 37). The
polymerase III-mediated mechanism may explain IFN induc-
tion by some DNA viruses or intracellular bacteria.
Nallagatla et al. suggested that the 5¢ tri-phosphate signature
is sensed by protein kinase R (PKR) in addition to dsRNA
(38). Further studies are required to elucidate the mechanism
by which the 5¢ tri-phosphate signature activates both RIG-I
and PKR and to understand its biological significance.
Viral RNA ligand for RLR
Garcin’s group (39) nicely showed this dsRNA-dependent
activation of RIG-I, using a SeV infection. They generated SeV
expressing GFP mRNA or antisense GFP mRNA and performed
co-infection of two types of SeV. They found that the resulting
capped dsRNA of GFP sequences induced an IFN response that
was dependent on RIG-I. In addition to engineered SeV, natu-
ral VSV, a ssRNA virus recognized by RIG-I, was shown to
produce dsRNA in infected cells (25). Induction of IFNs by
RNAs from VSV-infected cells was impaired by disrupting
dsRNA, suggesting the presence of dsRNA in VSV-infected
cells is important for RIG-I mediated IFN responses. The frag-
ments produced by VSV were about 2–2.5 kbp much shorter
than the length of the 11 kb VSV genomic RNA, suggesting
that these dsRNA were not derived from replication interme-
diates of VSV. Rather, the dsRNA maybe be derived from
defective interfering (DI) particles, whose snap-back dsRNAs
are reported to be about 2.2 kbp, generated in VSV-infected
cells, although the viral dsRNA signiture recognized by RIG-I
remains to be further characterized. Recently, panhandle
structure of the influenza virus genome is also reported as
RIG-I ligand (40). It is of interest to clarify which ligand is the
major source of RIG-I-dependent IFN production in individ-
ual viral infection.
IFN production induced by long segments purified from
the reovirus genome (about 3.9 kbp) is impaired in MDA5-
deficient cells (25). Further, the very large RNA species
(stuck at the top of the gel during electrophoresis) gener-
ated by EMCV or vaccinia virus infection is a specific ligand
for MDA5 (41). Although the precise structure of the RNA
(termed RNA web), is not known, a highly ordered struc-
ture is critical for this activity, as heat treatment inactivated
the complex.
RNaseL-cleaved RNA
RNaseL is an endonuclease thought to cleave viral RNA. Silver-
man’s group (42) showed that RNaseL-deficient cells showed
attenuated induction of IFN in response to poly I:C or Sendai
virus. In addition, in the infection with EMCV and Sendai
virus, RNaseL-deficient mice showed impaired IFN produc-
tion in sera. The RNaseL cleavage products activate RIG-I and
MDA5, leading to production of type I IFNs. This mechanism
potentially generates RLR ligands from self-RNA as well as
viral RNA.
Poly-U ⁄UC rich RNA
Infection with HCV is known to be regulated by hepatic
immune defense triggered by RIG-I. Mapping of the HCV
genome for RIG-I activation revealed that 5¢-triphosphate sig-
nature was necessary but not sufficient for the activation of
RIG-I and that a polyuridine motif (poly-U ⁄UC-rich region)
at the 3¢-non-translated region is critical for efficient activa-
tion of RIG-I (43). They extended their finding and found that
5¢-triphosphate genomic poly-U ⁄A-rich RNA motifs within
the rabies virus leader sequence, Ebola virus 3¢ region, and
measles virus leader sequence were also important for RIG-I
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activation (43). However, GC-rich RNA motifs failed to
induce the signaling (43). Thus, A ⁄U composition and poly-
U motifs are possible determinants of viral RNA recognition
by antiviral innate immunity.
Structure of RLRs
Two groups independently identified the RNA recognition
domain that is located to the C-terminus to the helicase
domain CTD. Takahasi et al. (11) showed that RIG-I CTD spe-
cifically binds dsRNA and 5¢-triphosphate RNA and solved its
solution structure. Furthermore, these studies revealed that
large positive charged surface that locates the center of the
structure is the RNA binding site by NMR titration (11). Cui
et al. also identified the domain and solved the crystal structure
(44). The structures of MDA5 and LGP2 CTDs were also
solved and their structural features are very similar to RIG-I
CTD (45). Recent studies have solved the crystal structures of
RIG-I CTD bound to both blunt ended double-strand RNA and
dsRNA with 5¢-triphosphate (46–48). Both CTD structures
showed that the same basic surface revealed in previous stud-
ies was essential for the RNA recognition. However, two dif-
ferent ended RNAs bound RIG-I CTD in different orientations
(46–48). The complex structure of LGP2 bound to the blunt
end of dsRNA was also solved by x-ray crystallography, but
the orientation of the RNA in the complex was also different
from the RNAs bound to the RIG-I CTD (49). The biological
significance of these co-crystals requires further investigation
because the biological activity of the RNA used for crystal is
not well investigated, particularly the presence or absence of
5¢-triphosphate. These observations imply that RIG-I specifi-
cally recognizes the end structure of viral RNA, especially
blunt end dsRNA or 5¢-triphosphate structure. However, it has
been controversial if end structure affects recognition by RIG-
I (11, 45, 46). In addition, AFM analysis suggests that RIG-I
aggregates around the short poly I:C, excluding the possibility
of end-specific binding (25). For certain, better understanding
of the activation of the RIG-I ⁄RNA complex awaits further
structural elucidation of inactive (free RIG-I in closed struc-
ture) and activated (RIG-I ⁄RNA complex in the presence of
ATP) complexes.
RLR signaling and its regulation
Upon binding to viral RNA in the presence of ATP, RIG-I
changes its conformation to expose the CARD. The activated
RIG-I forms oligomer, which allows the CARDs of RIG-I to
interact with a CARD-containing adapter, IPS-1, which is
localized on the outer membrane of the mitochondrion.
MDA5 also transduces signaling via IPS-1. IPS-1 subsequently
activates two IjB kinase (IKK)-related kinases, IKK-I, and
TANK-binding kinase 1 (TBK1) via tumor necrosis factor
(TNF) receptor-associated factor 3 (TRAF3) (50–52). These
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location from the cytoplasm into the nucleus, which activates
transcription of genes encoding type I IFNs and IFN-inducible
genes (53, 54). In addition, IPS-1 activates NF-jB via a FADD
and caspase-8 ⁄10 pathway to regulate the expression of proin-
flammatory cytokine genes (55).
Many molecules have been reported to modulate the RLR-
mediated signaling pathway (described above) through direct
interaction with RLRs or with signaling molecules. For
instance, Src homology 2 (SH2) domain-containing phospha-
tase-1 (SHP-1) is reported to activate RIG-I-mediated signal-
ing by binding directly to RIG-I (56). Dihydroacetone kinase
(DAK) was identified as a MDA5-interacting protein and was
shown to negatively regulate MDA5 (57). NLRX1 (also
known as NOD9) is localized to the mitochondrial outer
membranes and is suggested to function as a negative regula-
tor of IPS-1 via a direct interaction (58). Suppressor of IKKe
(SIKE) forms a complex with TBK1 ⁄ IKKe and inhibits the
interaction of RIG-I or IRFs with TBK1 ⁄ IKKe in the basal con-
dition, while viral infection leads to dissociation of SIKE from
TBK ⁄ IKKe (59). Molecules involved in the autophagic
machinery, Atg5-atg12, are reported to inhibit the interaction
between RIG-I and IPS-1 by association with the CARD of
RIG-I and with IPS-1 (60). Recent studies from two indepen-
dent groups (61, 62) identified the same signal-modulator
molecule, designated as stimulator of IFN genes (STING), also
called mediator of IRF-3 activation (MITA). STING is reported
to localize to the endoplasmic reticulum (ER) membrane, and
STING interacts with RIG-I (but not MDA5), and SSR2 ⁄TRPb
complex, required for protein translocation across the ER
membrane. The other group reported that STING is expressed
on the outer membrane of mitochondrion, where it interacts
directly with IPS-1 and IRF-3 and positively regulates the
virus-dependent recruitment of TBK1 to the IPS-1 complex on
mitochondrion.
Ubiquitination of RLRs is reported to control their signals
both positively and negatively. The CARDs of RIG-I undergo
Lys63-linked ubiquitination by tripartite motif 25 (TRIM 25),
and this ubiquitination is necessary for efficient activation of
RIG-I mediated signaling (63). Interestingly, MDA5 does not
undergo ubiquitination by TRIM25, suggesting that CARDs of
RIG-I and MDA5 are differentially regulated. A tumor suppres-
sor, CYLD (cylindomatosis), is reported to negatively regulate
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the RIG-I-mediated signaling by deubiquitinating the
TRIM25-mediated ubiquitination of RIG-I (64). Another E3
ubiquitin ligase RNF135 ⁄Riplet is shown to promote Lys63-
linked ubiquitination of the C-terminal region of RIG-I, which
results in activation of IFN promoter (65). RIG-I also
undergoes Lys48-linked polyubiquitination by the E3 ubiqu-
itin ligase RNF125, leading to its proteasomal degradation,
which inhibits aberrant activation of RIG-I mediated signaling.
Further, RNF125 conjugates ubiquitin to MDA5 as well as IPS-
1, which results in suppressing the functions of these proteins
(66). It was also recently shown that REUL is an E3 ubiquitin
ligase of RIG-I and specifically stimulates RIG-I-mediated IFN
signaling (67). The Lys 154, 164, and 172 residues of the
RIG-I CARD domain are critical for efficient REUL-mediated
ubiquitination, as well as the ability of RIG-I to induce activa-
tion of the IFN-b promoter. ISGylation also modulates RLR-
signaling. RIG-I is ISGylated by the ubiquitin-like protein,
ISG15, which regulates the activity of RNF125 together with
UbcH8, an E2 ubiquitin-conjugating enzyme (68). UbcH8
suppresses ubiquitination of RIG-I by RNF125, and the sup-
pression by UbcH8 is relieved by ISG15.
Artificial aggregation of IPS-1 in the cytoplasm is sufficient
for activation of antiviral signaling (69), suggesting that the
activity of IPS-1 is regulated by its oligomerization induced by
physical interaction of CARD of RIG-I or MDA5. Interestingly,
IPS-1 aggregation is observed in cells stably expressing Flag-
tagged IPS-1 upon infection by various viruses or 5¢-triphos-
phate RNA. Normally IPS-1 is localized on the outer mem-
brane of the mitochondrion, which may restrict its
movement. The IPS-1 aggregation requires mitofusin 1, a
mitochondrial regulator for its fusion (70). Mitofusin 1 is also
reported to be critical for mitochondrial elongation induced
by certain strains of Sendai virus. These results suggest that the
activity of IPS-1 requires dynamic fission and fusion of mito-
chondrion to facilitate efficient signaling by its oligomeriza-
tion. However, there are contradictory reports on the function
of mitochondrion and mitofusins (71).
In addition to host regulatory factors mentioned above,
viruses acquire means to evade antiviral immunity of the host.
Modification of viral RNA and assembly of nucleocapsid are
major strategies to escape from detection by RLRs. Viral non-
structural (NS) proteins often participate in the counteraction
of antiviral cascades. A large number of viral inhibitory pro-
teins have been identified that block RLR signaling at various
levels (reviewed in 72, 73).
Conclusions and perspectives
Cumulative studies based on RLR knockout mice ⁄ cells and
various viruses revealed the mechanism by which RLRs sense
viral invasion as well as viral strategies to evade antiviral
responses mediated by RLRs. As described in this review, it is
clear that RIG-I and MDA5 are essential sensors for RNA
viruses and that these helicases discriminate self and non-self
RNAs by precise recognition of virus-specific RNA signatures.
However, elucidation of many signaling regulators has made
the picture more complicated than previously appreciated.
Certainly, many interesting topics remain to be clarified,
including identification of the precise RNA ligands of RLRs
during viral infection, the reason why IPS-1 localizes to the
mitochondrion, and elucidation of the molecular structure of
inactive and active RIG-I.
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